Biopol Chemicals IPO: GMP, Price, Analysis, And Details

Biopol Chemicals IPO- Company Analysis 

Biopol Chemicals IPO under the SME IPO category is a bookbuild issue of Rs. 31.26 Cr by Biopol Chemicals Limited and is producing and distributing specialty chemicals that fall into the categories of polyelectrolytes, biochemicals, emulsifiers and silicones.

Forty silicone-based products, five emulsifier-based products, fifteen biochemical products, and six polyelectrolyte products make up its 66-product line. Textiles, home care, agriculture, and industrial chemicals are just a few of the industries that use these items.

Instead of serving retail end users, the company's business-to-business (B2B) approach targets institutional clientele.

Product:

• Chemicals for textiles

• In-home care

• Farming

• Chemicals used in industry

Biopol Chemicals IPO Details

The Biopol Chemicals IPO date of opening is 06 Feb 2026, its initial public offering will end on 10 Feb, IPO allotment on Feb 11 and refund initiation on Feb 12, 2026.

The Rs. 31.26 crore new SME IPO comprises a wholly fresh issue of 0.29 crore Shares.

The Biopol Chemicals IPO listing date (expected) might be on Friday, Feb 13, 2026, and listing at the NSE and SME. 

The Biopol Chemicals IPO price band is Rs. 102 to Rs. 108.

IPO Timetable (Tentative)

Click to open demat account and apply for the IPO.

Company Financials

(Amount in Cr)

Cash Flows

(Amount in lac)

Revenue Bifurcation

(Rs. in Lac)

(Source: RHP)

The Objective of the Issue

The company desires to use the Net Proceeds from the Issue to fulfill its following goals:

• Acquisition of industrial land. ~ Rs. 12.26 Cr.

• Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies. ~ Rs. 11.10 Cr.

• General Corporate Purposes. 

Listed Peers of Biopol Chemicals Ltd.

Valuation

Evaluation of P/E Ratio

Considering the period ended on FY 2025 with an EPS of Rs. 5.47 from the last year, the resulting P/E ratio is 19.74x.

Explore the Kanishk Aluminium India IPO.

IPO's Strengths

• Certification of Quality and Assurance of Quality.

• Strategic presence in West Bengal and Gujarat.

• Skilled Management Team and Promoter.

• Bangladeshi export activities.
  
  

IPO's Weaknesses

• The textile sector is crucial to business.

• To acquire essential raw materials, the company relies on a small number of suppliers.

• Geographical concentration risks.
  
  

Biopol Chemicals IPO GMP (Grey Market Premium)

Biopol Chemicals IPO GMP today has not started yet as of 28 Jan 2026 while writing this information. 

Biopol Chemicals IPO Summary

IPO Lot Details 

Retail investors can invest in a minimum of 2 Lots (2400 Shares) for Rs. 2,59,200, and in multiples thereof, while HNI investors can invest in a minimum of 3 Lots (3600 Shares) for Rs. 3,88,800.

Biopol Chemicals IPO Allotment Status

To check the Biopol Chemicals IPO Allotment Status, visit the official Registrar’s website or BSE website. Below are the website links for you.

Using BSE Website - "‹BSE IPO allotment status

Promoters And Management of Biopol Chemicals Ltd.

• Mr. Santanu Sarkar 

• Mr. Vedant Sarkar. 

IPO Lead Managers

• Smart Horizon Capital Advisors Pvt. Ltd.
  
  

Dividend Policy

The company has not paid a dividend during the last three years.

Conclusion

Biopol Chemicals IPO provides exposure to a specialty chemicals B2B player with robust revenue growth, strong margins, and improving return ratios. Reasonable valuation and transparent use of profits provide comfort, even though reliance on textiles and supplier concentration continue to be major threats.

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.